These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 13861903)
1. Biochemical and pharmacological properties of the metal-binding agent penicillamine. APOSHIAN HV Fed Proc; 1961 Sep; 20(3)Pt 2():185-8. PubMed ID: 13861903 [No Abstract] [Full Text] [Related]
2. Penicillamine: the pharmacology of a chelating agent. WALSHE JM Ann Intern Med; 1960 Nov; 53():1090-6. PubMed ID: 13782930 [No Abstract] [Full Text] [Related]
3. Penicillamine as lead-chelating substance in man. OHLSSON WT Br Med J; 1962 May; 1(5290):1454-6. PubMed ID: 14481385 [No Abstract] [Full Text] [Related]
4. Metal chelates of DL-penicillamine. KUCHINSKAS EJ; ROSEN Y Arch Biochem Biophys; 1962 May; 97():370-2. PubMed ID: 14460165 [No Abstract] [Full Text] [Related]
5. Penicillamine and vitamin B6 interrelationships in the rat. HEDDLE JG; McHENRY EW; BEATON GH Can J Biochem Physiol; 1963 May; 41():1215-22. PubMed ID: 13963670 [No Abstract] [Full Text] [Related]
6. [D-penicillamine, a new chelating agent]. PEROL R; GRAVELEAU J; MORIN M Sem Hop; 1962 Oct; 38():3337-8. PubMed ID: 13942526 [No Abstract] [Full Text] [Related]
7. Penicillamine - not only a chelating agent but also a potent neuroprotector in the neonatal period. Lakatos L; Balla G; Pataki I Chem Biol Interact; 2018 Aug; 291():190-191. PubMed ID: 29935160 [No Abstract] [Full Text] [Related]
8. Chemical and biological properties of toxic metals and use of chelating agents for the pharmacological treatment of metal poisoning. Sinicropi MS; Amantea D; Caruso A; Saturnino C Arch Toxicol; 2010 Jul; 84(7):501-20. PubMed ID: 20386880 [TBL] [Abstract][Full Text] [Related]
10. Metal element excretion in 24-h urine in patients with Wilson disease under treatment of D-penicillamine. Huang L; Yu X; Zhang J; Liu X; Zhang Y; Jiao X; Yu X Biol Trace Elem Res; 2012 May; 146(2):154-9. PubMed ID: 22076732 [TBL] [Abstract][Full Text] [Related]
11. [On Wilson's disease. Also a contribution on penicillamine therapy]. LANGE J; HAGER H Z Kinderheilkd; 1960; 84():125-36. PubMed ID: 13853564 [No Abstract] [Full Text] [Related]
12. Effect of thiol chelators on trace metal levels. Tandon SK; Behari JR; Ashquin M Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):501-4. PubMed ID: 6320321 [TBL] [Abstract][Full Text] [Related]
13. Metabolism in vitro of the sulphydryl amino acids, L- and D-penicillamine. APOSHIAN HV; BRADHAM LS Biochem Pharmacol; 1959 Dec; 3():38-41. PubMed ID: 13793949 [No Abstract] [Full Text] [Related]
14. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine. Borthwick TR; Benson GD; Schugar HJ J Lab Clin Med; 1980 Apr; 95(4):575-80. PubMed ID: 7359013 [TBL] [Abstract][Full Text] [Related]
15. D-Penicillamine as an antidote to 8-hydroxyquinoline and alloxan. MATSUDA M; MAKINO K Nature; 1961 Oct; 192():261-2. PubMed ID: 14471252 [No Abstract] [Full Text] [Related]
16. [Inhibition of enzymatic decarboxylation of amino acids by DL-penicillamine, L-cysteine and DL-homocysteine]. MARDASHEV SR; SEMINA LA Biokhimiia; 1961; 26():31-9. PubMed ID: 13766612 [No Abstract] [Full Text] [Related]
18. Chemical basis for pharmacological and therapeutic actions of penicillamine. Friedman M Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):50-60. PubMed ID: 122675 [No Abstract] [Full Text] [Related]
19. Binding of penicillamine to toxic metal ions: Synthesis and structure of potassium (D-penicillaminato) (L-penicillaminato)cobaltate(III) dihydrate, K[Co(D-pen)(L-pen)]-2H2O. Helis HM; de Meester P; Hodgson DJ J Am Chem Soc; 1977 May; 99(10):3309-12. PubMed ID: 853182 [No Abstract] [Full Text] [Related]
20. Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals. Goyer RA; Cherian MG; Jones MM; Reigart JR Environ Health Perspect; 1995 Nov; 103(11):1048-52. PubMed ID: 8605855 [No Abstract] [Full Text] [Related] [Next] [New Search]